154 related articles for article (PubMed ID: 21185266)
1. Cation-π and π-π stacking interactions allow selective inhibition of butyrylcholinesterase by modified quinine and cinchonidine alkaloids.
Nawaz SA; Ayaz M; Brandt W; Wessjohann LA; Westermann B
Biochem Biophys Res Commun; 2011 Jan; 404(4):935-40. PubMed ID: 21185266
[TBL] [Abstract][Full Text] [Related]
2. Chemical modifications of cinchona alkaloids lead to enhanced inhibition of human butyrylcholinesterase.
Karlsson D; Fallarero A; Shinde P; Anju CP; Busygin I; Leino R; Mohan CG; Vuorela P
Nat Prod Commun; 2014 Apr; 9(4):455-8. PubMed ID: 24868853
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
Musilek K; Komloova M; Zavadova V; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K; Jung YS
Bioorg Med Chem Lett; 2010 Mar; 20(5):1763-6. PubMed ID: 20138518
[TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffold.
Bosak A; Ramić A; Šmidlehner T; Hrenar T; Primožič I; Kovarik Z
PLoS One; 2018; 13(10):e0205193. PubMed ID: 30289893
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors.
Pisani L; Catto M; Giangreco I; Leonetti F; Nicolotti O; Stefanachi A; Cellamare S; Carotti A
ChemMedChem; 2010 Sep; 5(9):1616-30. PubMed ID: 20677317
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585
[TBL] [Abstract][Full Text] [Related]
8. Kinetics and structure-activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases.
Khalid A; Zaheer-ul-Haq ; Anjum S; Khan MR; Atta-ur-Rahman ; Choudhary MI
Bioorg Med Chem; 2004 May; 12(9):1995-2003. PubMed ID: 15080903
[TBL] [Abstract][Full Text] [Related]
9. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
Katalinić M; Rusak G; Domaćinović Barović J; Sinko G; Jelić D; Antolović R; Kovarik Z
Eur J Med Chem; 2010 Jan; 45(1):186-92. PubMed ID: 19879672
[TBL] [Abstract][Full Text] [Related]
10. Study on dual-site inhibitors of acetylcholinesterase: Highly potent derivatives of bis- and bifunctional huperzine B.
He XC; Feng S; Wang ZF; Shi Y; Zheng S; Xia Y; Jiang H; Tang XC; Bai D
Bioorg Med Chem; 2007 Feb; 15(3):1394-408. PubMed ID: 17126020
[TBL] [Abstract][Full Text] [Related]
11. Berberine derivatives, with substituted amino groups linked at the 9-position, as inhibitors of acetylcholinesterase/butyrylcholinesterase.
Huang L; Luo Z; He F; Shi A; Qin F; Li X
Bioorg Med Chem Lett; 2010 Nov; 20(22):6649-52. PubMed ID: 20880702
[TBL] [Abstract][Full Text] [Related]
12. alpha,beta-Dehydrophenylalanine choline esters, a new class of reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Grigoryan HA; Hambardzumyan AA; Mkrtchyan MV; Topuzyan VO; Halebyan GP; Asatryan RS
Chem Biol Interact; 2008 Jan; 171(1):108-16. PubMed ID: 17980356
[TBL] [Abstract][Full Text] [Related]
13. Rational design and synthesis of highly potent anti-acetylcholinesterase activity huperzine A derivatives.
Yan J; Sun L; Wu G; Yi P; Yang F; Zhou L; Zhang X; Li Z; Yang X; Luo H; Qiu M
Bioorg Med Chem; 2009 Oct; 17(19):6937-41. PubMed ID: 19726199
[TBL] [Abstract][Full Text] [Related]
14. Structural aspects of 4-aminoquinolines as reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Bosak A; Opsenica DM; Šinko G; Zlatar M; Kovarik Z
Chem Biol Interact; 2019 Aug; 308():101-109. PubMed ID: 31100281
[TBL] [Abstract][Full Text] [Related]
15. Docking and quantum mechanic studies on cholinesterases and their inhibitors.
Correa-Basurto J; Flores-Sandoval C; Marín-Cruz J; Rojo-Domínguez A; Espinoza-Fonseca LM; Trujillo-Ferrara JG
Eur J Med Chem; 2007 Jan; 42(1):10-9. PubMed ID: 17055616
[TBL] [Abstract][Full Text] [Related]
16. The exploration of thienothiazines as selective butyrylcholinesterase inhibitors.
Karlsson D; Fallarero A; Brunhofer G; Mayer C; Prakash O; Mohan CG; Vuorela P; Erker T
Eur J Pharm Sci; 2012 Aug; 47(1):190-205. PubMed ID: 22683890
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
[TBL] [Abstract][Full Text] [Related]
18. Novel aromatic-polyamine conjugates as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase.
Hong C; Luo W; Yao D; Su YB; Zhang X; Tian RG; Wang CJ
Bioorg Med Chem; 2014 Jun; 22(12):3213-9. PubMed ID: 24794747
[TBL] [Abstract][Full Text] [Related]
19. Derivatives of oxoisoaporphine alkaloids: a novel class of selective acetylcholinesterase inhibitors.
Tang H; Ning FX; Wei YB; Huang SL; Huang ZS; Chan AS; Gu LQ
Bioorg Med Chem Lett; 2007 Jul; 17(13):3765-8. PubMed ID: 17451950
[TBL] [Abstract][Full Text] [Related]
20. Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies.
Khan MT; Orhan I; Senol FS; Kartal M; Sener B; Dvorská M; Smejkal K; Slapetová T
Chem Biol Interact; 2009 Oct; 181(3):383-9. PubMed ID: 19596285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
